Cyltezo
- Licence status
- Withdrawn: 15/01/2019
- Active substances
- Adalimumab
- Dosage Form
- Solution for injection in pre-filled pen
- Licence number
- EU/1/17/1240/005-008
- Licence holder
- Boehringer Ingelheim International GmbH
Licence information
- ATC code
- L04AB Tumor necrosis factor alpha (TNF-) inhibitors, L04AB04 adalimumab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 10/11/2017